Prostate-specific membrane antigen (PSMA) is a protein that is overexpressed in 90% of advanced prostate tumors and the neovasculature of the tumor microenvironment of many types of advanced cancer, such as metastatic colon cancer, triple-negative breast cancer, and hepatocarcinoma, among others [12,13,14,15,16]. This evidence concerns the gene FOLH1 and prostate neoplasm.